The cells have a stably integrated NF-κB reporter plasmid, allowing for quantification of tumor NF-κB activity in response to drug treatment during intraperitoneal abdominal carcinomatosis accompanied by ascites formation. The gene discussed is NFKB1; the disease is neoplasm.